Glucomannan Lipid Profile Randomized Trial Evidence Table

Structured evidence table for Glucomannan Lipid Profile Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Glucomannan Lipid Profile Randomized TrialBackground Glucomannan has been studied for various health benefits, but its effects on lipid profile in adults are not well understood.1Musazadeh V (2024)The effect of glucomannan supplementation on lipid profile in adults: a GRADE-assessed systematic review and meta-analysis.
Glucomannan Lipid Profile Randomized TrialThis meta-analysis aims to evaluate the impact of glucomannan supplementation on serum/plasma levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), Apo B1, Apo A1, APO-B/ A1 ratio, and LDL-C/ HDL-C in adults.1Musazadeh V (2024)The effect of glucomannan supplementation on lipid profile in adults: a GRADE-assessed systematic review and meta-analysis.
Glucomannan Lipid Profile Randomized TrialThe primary therapeutic objective of T2DM management is to achieve optimal glycemic control while mitigating the risk factors of cardiovascular diseases, thereby reducing the likelihood of developing diabetes-related complications ().2Dehzad Mohammad Jafar (2025)Effects of Yogurt Enriched with Konjac Glucomannan and Inulin on Insulin Sensitivity, Glycemic Control, Lipid Profiles, Anthropometric Measures and Oxidative Stress in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
Glucomannan Lipid Profile Randomized TrialLow-fat dairy products, particularly yogurt, have been consistently associated with a reduced risk of developing and improved management of T2DM (;;).2Dehzad Mohammad Jafar (2025)Effects of Yogurt Enriched with Konjac Glucomannan and Inulin on Insulin Sensitivity, Glycemic Control, Lipid Profiles, Anthropometric Measures and Oxidative Stress in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
Glucomannan Lipid Profile Randomized TrialThese factors contribute to improved glucose control, insulin sensitivity, and weight management ().2Dehzad Mohammad Jafar (2025)Effects of Yogurt Enriched with Konjac Glucomannan and Inulin on Insulin Sensitivity, Glycemic Control, Lipid Profiles, Anthropometric Measures and Oxidative Stress in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
Glucomannan Lipid Profile Randomized TrialGalicia-Garcia et al., 2020 Jenkins et al., 2018 Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder that results from impaired insulin secretion by pancreatic β-cells and decreased insulin sensitivity in target tissues ().2Dehzad Mohammad Jafar (2025)Effects of Yogurt Enriched with Konjac Glucomannan and Inulin on Insulin Sensitivity, Glycemic Control, Lipid Profiles, Anthropometric Measures and Oxidative Stress in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
topicGlucomannan Lipid Profile Randomized Trial
claimBackground Glucomannan has been studied for various health benefits, but its effects on lipid profile in adults are not well understood.
evidence level1
citationMusazadeh V (2024)
sourceThe effect of glucomannan supplementation on lipid profile in adults: a GRADE-assessed systematic review and meta-analysis.
topicGlucomannan Lipid Profile Randomized Trial
claimThis meta-analysis aims to evaluate the impact of glucomannan supplementation on serum/plasma levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), Apo B1, Apo A1, APO-B/ A1 ratio, and LDL-C/ HDL-C in adults.
evidence level1
citationMusazadeh V (2024)
sourceThe effect of glucomannan supplementation on lipid profile in adults: a GRADE-assessed systematic review and meta-analysis.
topicGlucomannan Lipid Profile Randomized Trial
claimThe primary therapeutic objective of T2DM management is to achieve optimal glycemic control while mitigating the risk factors of cardiovascular diseases, thereby reducing the likelihood of developing diabetes-related complications ().
evidence level2
citationDehzad Mohammad Jafar (2025)
sourceEffects of Yogurt Enriched with Konjac Glucomannan and Inulin on Insulin Sensitivity, Glycemic Control, Lipid Profiles, Anthropometric Measures and Oxidative Stress in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
topicGlucomannan Lipid Profile Randomized Trial
claimLow-fat dairy products, particularly yogurt, have been consistently associated with a reduced risk of developing and improved management of T2DM (;;).
evidence level2
citationDehzad Mohammad Jafar (2025)
sourceEffects of Yogurt Enriched with Konjac Glucomannan and Inulin on Insulin Sensitivity, Glycemic Control, Lipid Profiles, Anthropometric Measures and Oxidative Stress in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
topicGlucomannan Lipid Profile Randomized Trial
claimThese factors contribute to improved glucose control, insulin sensitivity, and weight management ().
evidence level2
citationDehzad Mohammad Jafar (2025)
sourceEffects of Yogurt Enriched with Konjac Glucomannan and Inulin on Insulin Sensitivity, Glycemic Control, Lipid Profiles, Anthropometric Measures and Oxidative Stress in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
topicGlucomannan Lipid Profile Randomized Trial
claimGalicia-Garcia et al., 2020 Jenkins et al., 2018 Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder that results from impaired insulin secretion by pancreatic β-cells and decreased insulin sensitivity in target tissues ().
evidence level2
citationDehzad Mohammad Jafar (2025)
sourceEffects of Yogurt Enriched with Konjac Glucomannan and Inulin on Insulin Sensitivity, Glycemic Control, Lipid Profiles, Anthropometric Measures and Oxidative Stress in Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Source documents

  1. The effect of glucomannan supplementation on lipid profile in adults: a GRADE-assessed systematic review and meta-analysis.
  2. Effects of Yogurt Enriched with Konjac Glucomannan and Inulin on Insulin Sensitivity, Glycemic Control, Lipid Profiles, Anthropometric Measures and Oxidative Stress in Type 2 Diabetes Mellitus: A Randomized Controlled Trial